LIMN

Liminatus Pharma, Inc. Class A Common Stock

$3.25

Current Price

All

AI analysis

Read what the AI thinks of Liminatus Pharma, Inc. Class A Common Stock in the app.

Analyses are generated by AI from public data and are not investment advice.

Get the app

Key figures

Dividend per share

—

Yield

—

EPS

-$27.15

P/E

—

Data as of Oct 1

Why it matters for the long term

Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.

Upcoming events

Quarterly earnings

Nov 12

Posts

No posts about LIMN yet.